title: Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis.
authors.affiliation: Department of Neurology, Hokkaido Medical Center, Sapporo, Japan.
authors.forename: Naoya
authors.initials: N
authors.lastname: Minami
authors.forename: Naoto
authors.initials: N
authors.lastname: Fujiki
authors.forename: Shizuki
authors.initials: S
authors.lastname: Doi
authors.forename: Koji
authors.initials: K
authors.lastname: Shima
authors.forename: Masaaki
authors.initials: M
authors.lastname: Niino
authors.forename: Seiji
authors.initials: S
authors.lastname: Kikuchi
authors.forename: Hidenao
authors.initials: H
authors.lastname: Sasaki
mesh_terms: D000203:Activities of Daily Living; D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000276:immunology; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic; D011239:Prednisolone; D016559:Tacrolimus